Litcius/Paper detail

Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial

Constance Delaugerre, Frantz Foissac, Hendy Abdoul, Guillaume S. Masson, Laure Choupeaux, Éric Dufour, Nabil Gastli, Séverine Mercier‐Delarue, Marie Laure Néré, Marine Minier, Audrey Gabassi, Maud Salmona, Malika Seguineau, Sarah Schmitt, Sébastien Tonglet, Alexis Olivier, Claire Poyart, Jérôme Le Goff, X. Lescure, Solen Kernéis, Jean‐Marc Tréluyer

2021The Lancet Infectious Diseases50 citationsDOIOpen Access PDF

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Mass gatheringTransmission (telecommunications)Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakRandomized controlled trialMedical emergencyEmergency medicineEnvironmental healthVirologyOutbreakNursingDiseaseComputer scienceSurgeryInternal medicinePublic healthTelecommunicationsInfectious disease (medical specialty)Infection Control and VentilationSARS-CoV-2 detection and testingConferences and Exhibitions Management
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial | Litcius